Kataoka, Keiko http://orcid.org/0000-0002-8795-6536
Itagaki, Kanako
Hashiya, Nozumu
Wakugawa, Sorako
Tanaka, Koji
Nakayama, Makiko
Yamamoto, Akiko
Mukai, Ryo
Honjyo, Jyunichiro
Maruko, Ichiro
Kawai, Moeko
Miyara, Yasunori
Terao, Nobuhiro
Wakatsuki, Yu
Onoe, Hajime
Mori, Ryusaburo
Koizumi, Hideki
Sekiryu, Tetsuju
Iida, Tomohiro
Okada, Annabelle A.
Nakayama, Makiko
Yamamoto, Akiko
Kataoka, Keiko
Okada, Annabelle A.
Itagaki, Kanako
Ogasawara, Masashi
Honjyo, Junichiro
Mukai, Ryo
Sekiryu, Tetsuju
Hashiya, Nozomu
Maruko, Ichiro
Hasegawa, Taiji
Kawai, Moeko
Maruko, Ruka
Iida, Tomohiro
Wakugawa, Sorako
Miyara, Yasunori
Terao, Nobuhiro
Koizumi, Hideki
Tanaka, Koji
Onoe, Hajime
Wakatsuki, Yu
Mori, Ryusaburo
,
Article History
Received: 2 June 2023
Revised: 2 June 2023
Accepted: 22 August 2023
First Online: 5 September 2023
Declarations
:
: This retrospective study was conducted in accordance with the guidelines of the Helsinki Declaration. The Institutional Review Boards of Kyorin University, Fukushima Medical University, Tokyo Women’s Medical University, University of the Ryukyus, and Nihon University approved the study.
: Iida T. received grants from Nidek, Topcon, Santen, Novartis Pharma, Senju Pharmaceutical, Japan Alcon, HOYA, and AMO; consultant fee from Bayer Pharmaceuticals, Novartis Pharma, Chugai Pharmaceutical, Japan Boehringer Ingelheim, and Janssen Pharma; and received lecturing and travel fees from Bayer Pharmaceuticals, Novartis Pharma, Japan Alcon, Santen, Senju Pharmaceutical, Topcon, Chugai Pharmaceutical, Canon, Nidek, Otsuka Pharmaceutical, Nikon, and Kyowa Kirin. He holds a patent. Maruko I. received lecturing and travel fees from Bayer Pharmaceuticals, Novartis Pharma, Japan Alcon, Santen, Senju Pharmaceutical, Topcon, Chugai Pharmaceutical, Canon, Nidek, and Nikon. He holds a patent. Hasegawa T. received lecturing and travel fees from Bayer Pharmaceuticals, Novartis Pharma, Alcon Pharma, Santen, Kowa, Senju Pharmaceutical, R.E. Medical, Nikon Health Care Japan, JFC Sales Plan, Otsuka Pharmaceutical, and Japan Boehringer Ingelheim. Kawai M. has no conflict of interest. Maruko R received lecturing and travel fees from Kyowa Kirin. Koizumi H. received grants from Novartis Pharma, Alcon Pharma, Japan Alcon, Bayer Pharmaceuticals, HOYA, Senju Pharmaceutical, Santen Pharmaceutical, AMO, Otsuka Pharmaceutical, Star Japan, First Medical, Pfizer, Kowa, and Nikon; received lecturing and travel fees from Novartis Pharma, Alcon Pharma, Bayer Pharmaceuticals, Senju Pharmaceutical, Santen Pharmaceutical class, Kowa, Japan Alcon, HOYA, AMO, Otsuka Pharmaceutical, Pfizer, Bausch + Lomb Japan, JFC Sales Plan, Canon, Nidek, Abbott, Tomey, Daiichi Sankyo, Chugai Pharmaceutical, and Sanofi; and received consultant fee from Novartis Pharma, Bayer Pharmaceuticals, Chugai Pharmaceutical, Allergan, Japan Boehringer Ingelheim. Terao N. received lecturing and travel fees from Novartis Pharma, Bayer Pharmaceuticals, Santen Pharmaceutical, Abbott, Kowa, Topcon, Asahi Kasei Pharma, HOYA, and Chugai Pharmaceutical. Wakugawa S. received lecturing and travel fees from Senju Pharmaceutical and Novartis Pharma. Miyara Y. received lecturing and travel fees from Senju Pharmaceutical. Okada A. A. received grants from Alcon Pharma, Bayer Pharmaceuticals, Mitsubishi Tanabe Pharma, Pfizer, and Santen; received consultant fee from Apellis, Bayer Consumer Care AG, Bayer Pharmaceuticals, Biocon Biologics, Chugai Pharmaceutical, and Kowa; and received lecturing and travel fees from Bayer Australia, Bayer Pharmaceuticals, Chugai Pharmaceutical, Kowa, Mitsubishi Tanabe Pharma, Novartis Pharma, Santen, and Senju Pharmaceutical. Kataoka K. received lecturing and travel fees from Santen Pharmaceutical, Bayer Pharmaceuticals, Senju Pharmaceutical, Japan Boehringer Ingelheim, Otsuka Pharmaceutical, Canon Medtech, OMC Chugai Pharmaceutical, and Novartis Pharma. Yamamoto A. received lecturing and travel fees from Novartis Pharma, Bayer Pharmaceuticals, and Chugai Pharmaceutical. Nakayama M. has no conflict of interest. Ishiryu T. received grants from Novartis Pharma, Pfizer, Japan Alcon, Wakamoto Pharmaceutical, HOYA, Bayer Pharmaceuticals, Santen Pharmaceutical, Senju Pharmaceutical, AMO Japan, and Kowa; received lecturing and travel fees from Novartis Pharma, Chugai Pharmaceutical, Akura, Abbott, Alcon Pharma, Santen Pharmaceutical, and Senju Pharmaceutical; and received consultant fee from Allergan Japan. Mukai R. received lecturing and travel fees from Alcon Pharma, Chugai Pharmaceutical, and Senju Pharmaceutical. Itagaki K. received lecturing and travel fees from Novartis Pharma, Bayer, Santen Pharmaceutical, Senju Pharmaceutical, and Chugai Pharmaceutical. Ogasawara M. and Honjo J. have no conflict of interest. Mori R. received lecturing and travel fees from Santen Pharmaceutical, Bayer Pharmaceuticals, Japan Boehringer Ingelheim, and Kyowa Kirin and received lecturing and travel fees from Novartis Pharma, Senju Pharmaceutical, and Chugai Pharmaceutical. Tanaka K. received lecturing and travel fees from Santen Pharmaceutical, Alcon, Bayer Pharmaceuticals, Novartis Pharma, Senju Pharmaceutical, Nihon Tengan Kenkyusho, and Chugai Pharmaceutical. Wakatsuki Y. has no conflict of interest. Onoe M. received lecturing and travel fees from Novartis Pharma, Senju Pharmaceutical, and Chugai Pharmaceutical.